000950 重药控股
2024/03 - 三个月2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)0.9115.9829.30310.77810.460
总资产报酬率 ROA (%)0.1601.0851.7822.1832.604
投入资产回报率 ROIC (%)0.2781.7932.7953.4092.937

边际利润分析
销售毛利率 (%)7.7507.8748.5819.1789.364
营业利润率 (%)0.8821.2572.1162.4973.033
息税前利润/营业总收入 (%)2.2042.8843.7844.2674.591
净利润/营业总收入 (%)0.6870.9641.7152.0642.537

收益指标分析
经营活动净收益/利润总额(%)137.181107.83282.89486.85284.026
价值变动净收益/利润总额(%)55.13331.50220.07927.18322.222
营业外收支净额/利润总额(%)0.9170.1432.5451.2250.224

偿债能力分析
流动比率 (X)1.3201.2731.1981.3031.292
速动比率 (X)1.1241.0881.0041.1121.084
资产负债率 (%)75.87675.58877.77676.32575.301
带息债务/全部投入资本 (%)67.73766.89369.01066.250--
股东权益/带息债务 (%)44.60246.16942.10647.09749.389
股东权益/负债合计 (%)23.07423.42123.94625.89027.653
利息保障倍数 (X)1.6781.7752.3462.4532.959

营运能力分析
应收账款周转天数 (天)156.765137.903144.535137.3560.000
存货周转天数 (天)40.36938.50040.38837.1000.000